These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36076599)

  • 1. Aberrant peribiliary gland niche exacerbates fibrosis in primary sclerosing cholangitis and a potential therapeutic strategy.
    Wu S; Cao Y; Lu H; Qi X; Sun J; Ye Y; Gong L
    Biomed Pharmacother; 2022 Sep; 153():113512. PubMed ID: 36076599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
    Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
    J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoplastic Transformation of the Peribiliary Stem Cell Niche in Cholangiocarcinoma Arisen in Primary Sclerosing Cholangitis.
    Carpino G; Cardinale V; Folseraas T; Overi D; Grzyb K; Costantini D; Berloco PB; Di Matteo S; Karlsen TH; Alvaro D; Gaudio E
    Hepatology; 2019 Feb; 69(2):622-638. PubMed ID: 30102768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peribiliary Gland Niche Participates in Biliary Tree Regeneration in Mouse and in Human Primary Sclerosing Cholangitis.
    Carpino G; Nevi L; Overi D; Cardinale V; Lu WY; Di Matteo S; Safarikia S; Berloco PB; Venere R; Onori P; Franchitto A; Forbes SJ; Alvaro D; Gaudio E
    Hepatology; 2020 Mar; 71(3):972-989. PubMed ID: 31330051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis.
    Carpino G; Cardinale V; Renzi A; Hov JR; Berloco PB; Rossi M; Karlsen TH; Alvaro D; Gaudio E
    J Hepatol; 2015 Nov; 63(5):1220-8. PubMed ID: 26119688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis.
    De Muynck K; Heyerick L; De Ponti FF; Vanderborght B; Meese T; Van Campenhout S; Baudonck L; Gijbels E; Rodrigues PM; Banales JM; Vesterhuus M; Folseraas T; Scott CL; Vinken M; Van der Linden M; Hoorens A; Van Dorpe J; Lefere S; Geerts A; Van Nieuwerburgh F; Verhelst X; Van Vlierberghe H; Devisscher L
    Hepatology; 2024 Feb; 79(2):269-288. PubMed ID: 37535809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2
    Zhou T; Kyritsi K; Wu N; Francis H; Yang Z; Chen L; O'Brien A; Kennedy L; Ceci L; Meadows V; Kusumanchi P; Wu C; Baiocchi L; Skill NJ; Saxena R; Sybenga A; Xie L; Liangpunsakul S; Meng F; Alpini G; Glaser S
    EBioMedicine; 2019 Oct; 48():130-142. PubMed ID: 31522982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis.
    Zen Y; Liberal R; Nakanuma Y; Heaton N; Portmann B
    J Hepatol; 2013 Nov; 59(5):1059-64. PubMed ID: 23811304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of CCL24 in Primary Sclerosing Cholangitis: Bridging Patient Serum Proteomics to Preclinical Data.
    Greenman R; Snir T; Katav A; Aricha R; Mishalian I; Hay O; Frankel M; Lawler J; Saffioti F; Pinzani M; Thorburn D; Peled A; Mor A; Vaknin I
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
    Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
    J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lapachone ameliorates the progression of primary sclerosing cholangitis pathogenesis in rodent models.
    Woo SH; Lee SH; Moon SJ; Han J; Seo KS; Lee H; Lee CH; Hwang JH
    Life Sci; 2024 Jan; 337():122342. PubMed ID: 38092141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis.
    Tsuneyama K; Kono N; Yamashiro M; Kouda W; Sabit A; Sasaki M; Nakanuma Y
    J Pathol; 1999 Dec; 189(4):609-14. PubMed ID: 10629565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.
    Pollheimer MJ; Racedo S; Mikels-Vigdal A; Marshall D; Bowlus C; Lackner C; Madl T; Karlsen TH; Hov JR; Lyman SK; Adamkewicz J; Smith V; Moreau E; Zollner G; Eide TJ; Stojakovic T; Scharnagl H; Gruber HJ; Stauber RE; Trauner M; Fickert P
    J Hepatol; 2018 Aug; 69(2):368-377. PubMed ID: 29709678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models for primary sclerosing cholangitis.
    Vierling JM
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):591-610. PubMed ID: 11492970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into autoimmune cholangitis through animal models.
    Trauner M; Fickert P; Baghdasaryan A; Claudel T; Halilbasic E; Moustafa T; Wagner M; Zollner G
    Dig Dis; 2010; 28(1):99-104. PubMed ID: 20460897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescent cholangiocytes release extracellular vesicles that alter target cell phenotype via the epidermal growth factor receptor.
    Al Suraih MS; Trussoni CE; Splinter PL; LaRusso NF; O'Hara SP
    Liver Int; 2020 Oct; 40(10):2455-2468. PubMed ID: 32558183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic or pharmacological reduction of cholangiocyte senescence improves inflammation and fibrosis in the
    Alsuraih M; O'Hara SP; Woodrum JE; Pirius NE; LaRusso NF
    JHEP Rep; 2021 Jun; 3(3):100250. PubMed ID: 33870156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial glycoprotein 2 (GP2) in gallstones, bile fluid and peribiliary glands of patients with primary sclerosing cholangitis.
    Lopens S; Schierack P; Krause J; Piaszczyński M; Król R; Staroń R; Krupa Ł; Gutkowski K; Kruk B; Grąt M; Krawczyk M; Patkowski W; Glaser F; Rödiger S; Grossmann K; Pająk J; Milkiewicz P; Lammert F; Zieniewicz K; Schramm C; Roggenbuck D; Krawczyk M
    Clin Chim Acta; 2024 Aug; 562():119841. PubMed ID: 38964568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant adeno-associated virus 8-mediated inhibition of microRNA let-7a ameliorates sclerosing cholangitis in a clinically relevant mouse model.
    Hua H; Zhao QQ; Kalagbor MN; Yu GZ; Liu M; Bian ZR; Zhang BB; Yu Q; Xu YH; Tang RX; Zheng KY; Yan C
    World J Gastroenterol; 2024 Feb; 30(5):471-484. PubMed ID: 38414587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.